BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 23483542)

  • 1. Aggregation of polyQ-extended proteins is promoted by interaction with their natural coiled-coil partners.
    Petrakis S; Schaefer MH; Wanker EE; Andrade-Navarro MA
    Bioessays; 2013 Jun; 35(6):503-7. PubMed ID: 23483542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coiled-coil structure-dependent interactions between polyQ proteins and Foxo lead to dendrite pathology and behavioral defects.
    Kwon MJ; Han MH; Bagley JA; Hyeon DY; Ko BS; Lee YM; Cha IJ; Kim SY; Kim DY; Kim HM; Hwang D; Lee SB; Jan YN
    Proc Natl Acad Sci U S A; 2018 Nov; 115(45):E10748-E10757. PubMed ID: 30348793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA toxicity is a component of ataxin-3 degeneration in Drosophila.
    Li LB; Yu Z; Teng X; Bonini NM
    Nature; 2008 Jun; 453(7198):1107-11. PubMed ID: 18449188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aggregation of polyglutamine-expanded ataxin-3 sequesters its specific interacting partners into inclusions: implication in a loss-of-function pathology.
    Yang H; Li JJ; Liu S; Zhao J; Jiang YJ; Song AX; Hu HY
    Sci Rep; 2014 Sep; 4():6410. PubMed ID: 25231079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyglutamine tracts regulate beclin 1-dependent autophagy.
    Ashkenazi A; Bento CF; Ricketts T; Vicinanza M; Siddiqi F; Pavel M; Squitieri F; Hardenberg MC; Imarisio S; Menzies FM; Rubinsztein DC
    Nature; 2017 May; 545(7652):108-111. PubMed ID: 28445460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Essential role of coiled coils for aggregation and activity of Q/N-rich prions and PolyQ proteins.
    Fiumara F; Fioriti L; Kandel ER; Hendrickson WA
    Cell; 2010 Dec; 143(7):1121-35. PubMed ID: 21183075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-domain misfolding: understanding the aggregation pathway of polyglutamine proteins.
    Saunders HM; Bottomley SP
    Protein Eng Des Sel; 2009 Aug; 22(8):447-51. PubMed ID: 19589877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modifier pathways in polyglutamine (PolyQ) diseases: from genetic screens to drug targets.
    Costa MD; Maciel P
    Cell Mol Life Sci; 2022 May; 79(5):274. PubMed ID: 35503478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autophagy genes protect against disease caused by polyglutamine expansion proteins in Caenorhabditis elegans.
    Jia K; Hart AC; Levine B
    Autophagy; 2007; 3(1):21-5. PubMed ID: 17172799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Large-scale screen for modifiers of ataxin-3-derived polyglutamine-induced toxicity in Drosophila.
    VoSSfeldt H; Butzlaff M; PrüSSing K; Ní Chárthaigh RA; Karsten P; Lankes A; Hamm S; Simons M; Adryan B; Schulz JB; Voigt A
    PLoS One; 2012; 7(11):e47452. PubMed ID: 23139745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RACK1 modulates polyglutamine-induced neurodegeneration by promoting ERK degradation in Drosophila.
    Xie J; Han Y; Wang T
    PLoS Genet; 2021 May; 17(5):e1009558. PubMed ID: 33983927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small heat-shock proteins interact with a flanking domain to suppress polyglutamine aggregation.
    Robertson AL; Headey SJ; Saunders HM; Ecroyd H; Scanlon MJ; Carver JA; Bottomley SP
    Proc Natl Acad Sci U S A; 2010 Jun; 107(23):10424-9. PubMed ID: 20484674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxicity and aggregation of the polyglutamine disease protein, ataxin-3 is regulated by its binding to VCP/p97 in Drosophila melanogaster.
    Ristic G; Sutton JR; Libohova K; Todi SV
    Neurobiol Dis; 2018 Aug; 116():78-92. PubMed ID: 29704548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigallocatechin-3-gallate and tetracycline differently affect ataxin-3 fibrillogenesis and reduce toxicity in spinocerebellar ataxia type 3 model.
    Bonanomi M; Natalello A; Visentin C; Pastori V; Penco A; Cornelli G; Colombo G; Malabarba MG; Doglia SM; Relini A; Regonesi ME; Tortora P
    Hum Mol Genet; 2014 Dec; 23(24):6542-52. PubMed ID: 25030034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coiled-coil motifs enhance the toxicity of polyQ proteins (comment on DOI 10.1002/bies.201300001).
    Krzyzosiak WJ
    Bioessays; 2013 Jun; 35(6):500. PubMed ID: 23674356
    [No Abstract]   [Full Text] [Related]  

  • 16. The novel hydroxylamine derivative NG-094 suppresses polyglutamine protein toxicity in Caenorhabditis elegans.
    Haldimann P; Muriset M; Vígh L; Goloubinoff P
    J Biol Chem; 2011 May; 286(21):18784-94. PubMed ID: 21471208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyglutamine and neurodegeneration: structural aspects.
    Masino L
    Protein Pept Lett; 2004 Jun; 11(3):239-48. PubMed ID: 15182225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A huntingtin peptide inhibits polyQ-huntingtin associated defects.
    Arribat Y; Bonneaud N; Talmat-Amar Y; Layalle S; Parmentier ML; Maschat F
    PLoS One; 2013; 8(7):e68775. PubMed ID: 23861941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteostasis of polyglutamine varies among neurons and predicts neurodegeneration.
    Tsvetkov AS; Arrasate M; Barmada S; Ando DM; Sharma P; Shaby BA; Finkbeiner S
    Nat Chem Biol; 2013 Sep; 9(9):586-92. PubMed ID: 23873212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A genetic screening strategy identifies novel regulators of the proteostasis network.
    Silva MC; Fox S; Beam M; Thakkar H; Amaral MD; Morimoto RI
    PLoS Genet; 2011 Dec; 7(12):e1002438. PubMed ID: 22242008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.